Diseases affecting the anterior segment of the eye are the primary causes of vision
impairment and blindness globally. Drug administration through the topical ocular route is …

One of the major impediments to drug development is low aqueous solubility and thus poor
bioavailability, which leads to insufficient clinical utility. Around 70–80% of drugs in the …

Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …

The eye is the specialized part of the body and is comprised of numerous physiological
ocular barriers that limit the drug absorption at the action site. Regardless of various efforts …

An increasing number of people worldwide are affected by eye diseases, eventually leading
to visual impairment or complete blindness. Conventional treatment involves the use of eye …

Ocular disorders comprising various diseases of the anterior and posterior segments are
considered as the main reasons for blindness. Natural products have been identified as …

Purpose Apatinib (Apa) is a novel anti-vascular endothelial growth factor with the potential to
treat diabetic retinopathy (DR); a serious condition leading to visual impairment and …

Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic
retinopathy (DR) are vital factor that seriously threatens human vision health and quality of …

Nanoemulsions are liquid-in-liquid dispersion with a droplet size of about 100 nm. They
have a transparent appearance, high rate of bioavailability, and increased shelf life …

The eye, an intricate organ comprising physical and physiological barriers, poses a
significant challenge for ophthalmic physicians seeking to treat serious ocular diseases …